Rhythm Pharmaceuticals Inc.
RYTM | NASDAQ
$105.02
-$5.66 (-5.11%)
At close: Nov 5, 2026, 4:00 PM ET
$105.00
-$0.02 (-0.02%)
After-hours:
Nov 5, 2026, 5:08 PM ET
Fiscal Year Period Ending | FY 2025 Dec 31, 2025 | FY 2024 Dec 31, 2024 | FY 2023 Dec 31, 2023 | FY 2022 Dec 31, 2022 | FY 2021 Dec 31, 2021 | FY 2020 Dec 31, 2020 |
|---|---|---|---|---|---|---|
Revenue | 189.76M | 130.13M | 77.43M | 23.64M | 3.15M | n/a |
Cost of Revenue | 19.49M | 13.37M | 9.3M | 2.13M | 599K | 690K |
Gross Profit | 170.27M | 116.76M | 68.13M | 21.51M | 2.56M | -690K |
Operating Income | -192.02M | -265.5M | -184.36M | -179.16M | -170.06M | -136.58M |
Interest Income | 15.29M | 14.71M | 13.95M | 4.03M | 447K | 2.58M |
Pretax Income | -196.04M | -260.26M | -184.11M | -181.12M | -69.61M | -134M |
Net Income | -196.54M | -260.6M | -184.68M | -181.12M | -69.61M | -130.73M |
Selling & General & Admin | 194.94M | 144.3M | 117.53M | 92.03M | 68.49M | 46.13M |
Research & Development | 167.34M | 237.96M | 134.95M | 108.63M | 104.13M | 90.45M |
Other Expenses | n/a | n/a | n/a | n/a | n/a | -690K |
Operating Expenses | 362.28M | 382.26M | 252.48M | 200.66M | 172.61M | 135.89M |
Interest Expense | 20.58M | 20.6M | 13.89M | 5.2M | n/a | n/a |
Selling & Marketing Expenses | n/a | n/a | n/a | n/a | n/a | n/a |
Cost & Expenses | 381.77M | 395.63M | 261.79M | 202.8M | 173.21M | 136.58M |
Income Tax Expense | 497K | 346K | 564K | n/a | n/a | n/a |
Shares Outstanding (Basic) | 64.98M | 61M | 57.67M | 52.12M | 49.6M | 44.13M |
Shares Outstanding (Diluted) | 64.98M | 61M | 57.67M | 52.12M | 49.6M | 44.13M |
EPS (Basic) | -3.11 | -4.34 | -3.20 | -3.51 | -1.37 | -2.96 |
EPS (Diluted) | -3.11 | -4.34 | -3.20 | -3.51 | -1.37 | -2.96 |
EBITDA | -174.12M | -238.09M | -168.46M | -174.25M | -68.45M | -135.89M |
EBIT | -175.46M | -239.65M | -170.22M | -175.92M | -69.61M | -136.58M |
Depreciation & Amortization | 1.34M | 1.56M | 1.76M | 1.67M | 1.16M | 690K |
Add to Watchlist
Select watchlists to add or remove RYTM